Verified 2026-2035 Industry Projections
pravinwadeusa@gmail.com
Report Category Intelligence Hub

Healthcare & Biotechnology Market Research Reports

Global market dynamics across pharmaceuticals, medical devices, gene therapy, GLP-1 weight loss, and clinical diagnostics.

Average CAGR: 8.4% - 38.5%
Addressable Sector Size: $2.8 Trillion
Available Reports: 100+
Showing 100 market research reportsUpdated August 2026
Healthcare & BiotechnologyCode: AMR-HEA-1001CAGR: 10.2%

Artificial Intelligence in Healthcare Market Size, Share & Growth Report 2026-2035

The Global Artificial Intelligence in Healthcare Market size was valued at USD 8 Billion in 2025 and is projected to reach USD 16.2 Billion by 2035, expanding at a CAGR of 10.2%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026281 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,450
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1002CAGR: 13.9%

GLP-1 Weight Loss Therapeutics Market Size, Share & Growth Report 2026-2035

The Global GLP-1 Weight Loss Therapeutics Market size was valued at USD 12.8 Billion in 2025 and is projected to reach USD 30.6 Billion by 2035, expanding at a CAGR of 13.9%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026282 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,500
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1003CAGR: 17.6%

Gene Therapy & CRISPR Market Size, Share & Growth Report 2026-2035

The Global Gene Therapy & CRISPR Market size was valued at USD 17.6 Billion in 2025 and is projected to reach USD 48.6 Billion by 2035, expanding at a CAGR of 17.6%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026283 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,550
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1004CAGR: 21.3%

Clinical Trial Data Analytics Market Size, Share & Growth Report 2026-2035

The Global Clinical Trial Data Analytics Market size was valued at USD 22.4 Billion in 2025 and is projected to reach USD 70.1 Billion by 2035, expanding at a CAGR of 21.3%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026284 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,600
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1005CAGR: 25%

Digital Pathology Systems Market Size, Share & Growth Report 2026-2035

The Global Digital Pathology Systems Market size was valued at USD 27.2 Billion in 2025 and is projected to reach USD 95.2 Billion by 2035, expanding at a CAGR of 25%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026285 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,650
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1006CAGR: 28.7%

Surgical Robotics Equipment Market Size, Share & Growth Report 2026-2035

The Global Surgical Robotics Equipment Market size was valued at USD 32 Billion in 2025 and is projected to reach USD 123.8 Billion by 2035, expanding at a CAGR of 28.7%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026286 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,700
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1007CAGR: 32.4%

Next-Gen Sequencing NGS Market Size, Share & Growth Report 2026-2035

The Global Next-Gen Sequencing NGS Market size was valued at USD 36.8 Billion in 2025 and is projected to reach USD 156 Billion by 2035, expanding at a CAGR of 32.4%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026287 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,750
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1008CAGR: 36.1%

Liquid Biopsy Cancer Diagnostics Market Size, Share & Growth Report 2026-2035

The Global Liquid Biopsy Cancer Diagnostics Market size was valued at USD 41.6 Billion in 2025 and is projected to reach USD 191.8 Billion by 2035, expanding at a CAGR of 36.1%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026288 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,800
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1009CAGR: 7.8%

In Silico Drug Discovery Market Size, Share & Growth Report 2026-2035

The Global In Silico Drug Discovery Market size was valued at USD 46.4 Billion in 2025 and is projected to reach USD 82.6 Billion by 2035, expanding at a CAGR of 7.8%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026289 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,850
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1010CAGR: 11.5%

Cell Therapy Manufacturing Market Size, Share & Growth Report 2026-2035

The Global Cell Therapy Manufacturing Market size was valued at USD 51.2 Billion in 2025 and is projected to reach USD 110.1 Billion by 2035, expanding at a CAGR of 11.5%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026290 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,900
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1011CAGR: 15.2%

MRNA Vaccines & Therapeutics Market Size, Share & Growth Report 2026-2035

The Global MRNA Vaccines & Therapeutics Market size was valued at USD 56 Billion in 2025 and is projected to reach USD 141.1 Billion by 2035, expanding at a CAGR of 15.2%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026291 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,950
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1012CAGR: 18.9%

Radiopharmaceuticals & Nuclear Medicine Market Size, Share & Growth Report 2026-2035

The Global Radiopharmaceuticals & Nuclear Medicine Market size was valued at USD 60.8 Billion in 2025 and is projected to reach USD 175.7 Billion by 2035, expanding at a CAGR of 18.9%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026292 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,000
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1013CAGR: 22.6%

Artificial Intelligence in Healthcare Phase 2 Market Size, Share & Growth Report 2026-2035

The Global Artificial Intelligence in Healthcare Market size was valued at USD 65.6 Billion in 2025 and is projected to reach USD 213.9 Billion by 2035, expanding at a CAGR of 22.6%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026293 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,050
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1014CAGR: 26.3%

GLP-1 Weight Loss Therapeutics Phase 2 Market Size, Share & Growth Report 2026-2035

The Global GLP-1 Weight Loss Therapeutics Market size was valued at USD 70.4 Billion in 2025 and is projected to reach USD 255.6 Billion by 2035, expanding at a CAGR of 26.3%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026294 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,100
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1015CAGR: 30%

Gene Therapy & CRISPR Phase 2 Market Size, Share & Growth Report 2026-2035

The Global Gene Therapy & CRISPR Market size was valued at USD 75.2 Billion in 2025 and is projected to reach USD 300.8 Billion by 2035, expanding at a CAGR of 30%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026295 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,150
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1016CAGR: 33.7%

Clinical Trial Data Analytics Phase 2 Market Size, Share & Growth Report 2026-2035

The Global Clinical Trial Data Analytics Market size was valued at USD 80 Billion in 2025 and is projected to reach USD 349.6 Billion by 2035, expanding at a CAGR of 33.7%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026296 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,200
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1017CAGR: 37.4%

Digital Pathology Systems Phase 2 Market Size, Share & Growth Report 2026-2035

The Global Digital Pathology Systems Market size was valued at USD 84.8 Billion in 2025 and is projected to reach USD 402 Billion by 2035, expanding at a CAGR of 37.4%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026297 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,250
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1018CAGR: 9.1%

Surgical Robotics Equipment Phase 2 Market Size, Share & Growth Report 2026-2035

The Global Surgical Robotics Equipment Market size was valued at USD 89.6 Billion in 2025 and is projected to reach USD 171.1 Billion by 2035, expanding at a CAGR of 9.1%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026298 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,400
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1019CAGR: 12.8%

Next-Gen Sequencing NGS Phase 2 Market Size, Share & Growth Report 2026-2035

The Global Next-Gen Sequencing NGS Market size was valued at USD 94.4 Billion in 2025 and is projected to reach USD 215.2 Billion by 2035, expanding at a CAGR of 12.8%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026299 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,450
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1020CAGR: 16.5%

Liquid Biopsy Cancer Diagnostics Phase 2 Market Size, Share & Growth Report 2026-2035

The Global Liquid Biopsy Cancer Diagnostics Market size was valued at USD 99.2 Billion in 2025 and is projected to reach USD 262.9 Billion by 2035, expanding at a CAGR of 16.5%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026300 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,500
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1021CAGR: 20.2%

In Silico Drug Discovery Phase 2 Market Size, Share & Growth Report 2026-2035

The Global In Silico Drug Discovery Market size was valued at USD 104 Billion in 2025 and is projected to reach USD 314.1 Billion by 2035, expanding at a CAGR of 20.2%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026301 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,550
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1022CAGR: 23.9%

Cell Therapy Manufacturing Phase 2 Market Size, Share & Growth Report 2026-2035

The Global Cell Therapy Manufacturing Market size was valued at USD 108.8 Billion in 2025 and is projected to reach USD 368.8 Billion by 2035, expanding at a CAGR of 23.9%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026302 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,600
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1023CAGR: 27.6%

MRNA Vaccines & Therapeutics Phase 2 Market Size, Share & Growth Report 2026-2035

The Global MRNA Vaccines & Therapeutics Market size was valued at USD 113.6 Billion in 2025 and is projected to reach USD 427.1 Billion by 2035, expanding at a CAGR of 27.6%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026303 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,650
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1024CAGR: 31.3%

Radiopharmaceuticals & Nuclear Medicine Phase 3 Market Size, Share & Growth Report 2026-2035

The Global Radiopharmaceuticals & Nuclear Medicine Market size was valued at USD 118.4 Billion in 2025 and is projected to reach USD 489 Billion by 2035, expanding at a CAGR of 31.3%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026304 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,700
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1025CAGR: 35%

Artificial Intelligence in Healthcare Phase 3 Market Size, Share & Growth Report 2026-2035

The Global Artificial Intelligence in Healthcare Market size was valued at USD 123.2 Billion in 2025 and is projected to reach USD 554.4 Billion by 2035, expanding at a CAGR of 35%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026305 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,750
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1026CAGR: 6.7%

GLP-1 Weight Loss Therapeutics Phase 3 Market Size, Share & Growth Report 2026-2035

The Global GLP-1 Weight Loss Therapeutics Market size was valued at USD 128 Billion in 2025 and is projected to reach USD 213.8 Billion by 2035, expanding at a CAGR of 6.7%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026306 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,800
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1027CAGR: 10.4%

Gene Therapy & CRISPR Phase 3 Market Size, Share & Growth Report 2026-2035

The Global Gene Therapy & CRISPR Market size was valued at USD 132.8 Billion in 2025 and is projected to reach USD 270.9 Billion by 2035, expanding at a CAGR of 10.4%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026307 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,850
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1028CAGR: 14.1%

Clinical Trial Data Analytics Phase 3 Market Size, Share & Growth Report 2026-2035

The Global Clinical Trial Data Analytics Market size was valued at USD 137.6 Billion in 2025 and is projected to reach USD 331.6 Billion by 2035, expanding at a CAGR of 14.1%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026308 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,900
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1029CAGR: 17.8%

Digital Pathology Systems Phase 3 Market Size, Share & Growth Report 2026-2035

The Global Digital Pathology Systems Market size was valued at USD 142.4 Billion in 2025 and is projected to reach USD 395.9 Billion by 2035, expanding at a CAGR of 17.8%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026309 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,950
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1030CAGR: 21.5%

Surgical Robotics Equipment Phase 3 Market Size, Share & Growth Report 2026-2035

The Global Surgical Robotics Equipment Market size was valued at USD 147.2 Billion in 2025 and is projected to reach USD 463.7 Billion by 2035, expanding at a CAGR of 21.5%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026310 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,000
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1031CAGR: 25.2%

Next-Gen Sequencing NGS Phase 3 Market Size, Share & Growth Report 2026-2035

The Global Next-Gen Sequencing NGS Market size was valued at USD 152 Billion in 2025 and is projected to reach USD 535 Billion by 2035, expanding at a CAGR of 25.2%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026311 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,050
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1032CAGR: 28.9%

Liquid Biopsy Cancer Diagnostics Phase 3 Market Size, Share & Growth Report 2026-2035

The Global Liquid Biopsy Cancer Diagnostics Market size was valued at USD 156.8 Billion in 2025 and is projected to reach USD 610 Billion by 2035, expanding at a CAGR of 28.9%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026312 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,100
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1033CAGR: 32.6%

In Silico Drug Discovery Phase 3 Market Size, Share & Growth Report 2026-2035

The Global In Silico Drug Discovery Market size was valued at USD 161.6 Billion in 2025 and is projected to reach USD 688.4 Billion by 2035, expanding at a CAGR of 32.6%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026313 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,150
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1034CAGR: 36.3%

Cell Therapy Manufacturing Phase 3 Market Size, Share & Growth Report 2026-2035

The Global Cell Therapy Manufacturing Market size was valued at USD 166.4 Billion in 2025 and is projected to reach USD 770.4 Billion by 2035, expanding at a CAGR of 36.3%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026314 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,200
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1035CAGR: 8%

MRNA Vaccines & Therapeutics Phase 3 Market Size, Share & Growth Report 2026-2035

The Global MRNA Vaccines & Therapeutics Market size was valued at USD 171.2 Billion in 2025 and is projected to reach USD 308.2 Billion by 2035, expanding at a CAGR of 8%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026315 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,250
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1036CAGR: 11.7%

Radiopharmaceuticals & Nuclear Medicine Phase 4 Market Size, Share & Growth Report 2026-2035

The Global Radiopharmaceuticals & Nuclear Medicine Market size was valued at USD 176 Billion in 2025 and is projected to reach USD 381.9 Billion by 2035, expanding at a CAGR of 11.7%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026316 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,400
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1037CAGR: 15.4%

Artificial Intelligence in Healthcare Phase 4 Market Size, Share & Growth Report 2026-2035

The Global Artificial Intelligence in Healthcare Market size was valued at USD 180.8 Billion in 2025 and is projected to reach USD 459.2 Billion by 2035, expanding at a CAGR of 15.4%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026317 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,450
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1038CAGR: 19.1%

GLP-1 Weight Loss Therapeutics Phase 4 Market Size, Share & Growth Report 2026-2035

The Global GLP-1 Weight Loss Therapeutics Market size was valued at USD 5.6 Billion in 2025 and is projected to reach USD 16.3 Billion by 2035, expanding at a CAGR of 19.1%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026318 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,500
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1039CAGR: 22.8%

Gene Therapy & CRISPR Phase 4 Market Size, Share & Growth Report 2026-2035

The Global Gene Therapy & CRISPR Market size was valued at USD 10.4 Billion in 2025 and is projected to reach USD 34.1 Billion by 2035, expanding at a CAGR of 22.8%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026319 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,550
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1040CAGR: 26.5%

Clinical Trial Data Analytics Phase 4 Market Size, Share & Growth Report 2026-2035

The Global Clinical Trial Data Analytics Market size was valued at USD 15.2 Billion in 2025 and is projected to reach USD 55.5 Billion by 2035, expanding at a CAGR of 26.5%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026320 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,600
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1041CAGR: 30.2%

Digital Pathology Systems Phase 4 Market Size, Share & Growth Report 2026-2035

The Global Digital Pathology Systems Market size was valued at USD 20 Billion in 2025 and is projected to reach USD 80.4 Billion by 2035, expanding at a CAGR of 30.2%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026321 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,650
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1042CAGR: 33.9%

Surgical Robotics Equipment Phase 4 Market Size, Share & Growth Report 2026-2035

The Global Surgical Robotics Equipment Market size was valued at USD 24.8 Billion in 2025 and is projected to reach USD 108.9 Billion by 2035, expanding at a CAGR of 33.9%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026322 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,700
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1043CAGR: 37.6%

Next-Gen Sequencing NGS Phase 4 Market Size, Share & Growth Report 2026-2035

The Global Next-Gen Sequencing NGS Market size was valued at USD 29.6 Billion in 2025 and is projected to reach USD 140.9 Billion by 2035, expanding at a CAGR of 37.6%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026323 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,750
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1044CAGR: 9.3%

Liquid Biopsy Cancer Diagnostics Phase 4 Market Size, Share & Growth Report 2026-2035

The Global Liquid Biopsy Cancer Diagnostics Market size was valued at USD 34.4 Billion in 2025 and is projected to reach USD 66.4 Billion by 2035, expanding at a CAGR of 9.3%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026324 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,800
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1045CAGR: 13%

In Silico Drug Discovery Phase 4 Market Size, Share & Growth Report 2026-2035

The Global In Silico Drug Discovery Market size was valued at USD 39.2 Billion in 2025 and is projected to reach USD 90.2 Billion by 2035, expanding at a CAGR of 13%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026325 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,850
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1046CAGR: 16.7%

Cell Therapy Manufacturing Phase 4 Market Size, Share & Growth Report 2026-2035

The Global Cell Therapy Manufacturing Market size was valued at USD 44 Billion in 2025 and is projected to reach USD 117.5 Billion by 2035, expanding at a CAGR of 16.7%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026326 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,900
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1047CAGR: 20.4%

MRNA Vaccines & Therapeutics Phase 4 Market Size, Share & Growth Report 2026-2035

The Global MRNA Vaccines & Therapeutics Market size was valued at USD 48.8 Billion in 2025 and is projected to reach USD 148.4 Billion by 2035, expanding at a CAGR of 20.4%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026327 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,950
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1048CAGR: 24.1%

Radiopharmaceuticals & Nuclear Medicine Phase 5 Market Size, Share & Growth Report 2026-2035

The Global Radiopharmaceuticals & Nuclear Medicine Market size was valued at USD 53.6 Billion in 2025 and is projected to reach USD 182.8 Billion by 2035, expanding at a CAGR of 24.1%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026328 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,000
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1049CAGR: 27.8%

Artificial Intelligence in Healthcare Phase 5 Market Size, Share & Growth Report 2026-2035

The Global Artificial Intelligence in Healthcare Market size was valued at USD 58.4 Billion in 2025 and is projected to reach USD 220.8 Billion by 2035, expanding at a CAGR of 27.8%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026329 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,050
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1050CAGR: 31.5%

GLP-1 Weight Loss Therapeutics Phase 5 Market Size, Share & Growth Report 2026-2035

The Global GLP-1 Weight Loss Therapeutics Market size was valued at USD 63.2 Billion in 2025 and is projected to reach USD 262.3 Billion by 2035, expanding at a CAGR of 31.5%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026330 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,100
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1051CAGR: 35.2%

Gene Therapy & CRISPR Phase 5 Market Size, Share & Growth Report 2026-2035

The Global Gene Therapy & CRISPR Market size was valued at USD 68 Billion in 2025 and is projected to reach USD 307.4 Billion by 2035, expanding at a CAGR of 35.2%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026331 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,150
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1052CAGR: 6.9%

Clinical Trial Data Analytics Phase 5 Market Size, Share & Growth Report 2026-2035

The Global Clinical Trial Data Analytics Market size was valued at USD 72.8 Billion in 2025 and is projected to reach USD 123 Billion by 2035, expanding at a CAGR of 6.9%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026332 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,200
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1053CAGR: 10.6%

Digital Pathology Systems Phase 5 Market Size, Share & Growth Report 2026-2035

The Global Digital Pathology Systems Market size was valued at USD 77.6 Billion in 2025 and is projected to reach USD 159.9 Billion by 2035, expanding at a CAGR of 10.6%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026333 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,250
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1054CAGR: 14.3%

Surgical Robotics Equipment Phase 5 Market Size, Share & Growth Report 2026-2035

The Global Surgical Robotics Equipment Market size was valued at USD 82.4 Billion in 2025 and is projected to reach USD 200.2 Billion by 2035, expanding at a CAGR of 14.3%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026334 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,400
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1055CAGR: 18%

Next-Gen Sequencing NGS Phase 5 Market Size, Share & Growth Report 2026-2035

The Global Next-Gen Sequencing NGS Market size was valued at USD 87.2 Billion in 2025 and is projected to reach USD 244.2 Billion by 2035, expanding at a CAGR of 18%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026335 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,450
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1056CAGR: 21.7%

Liquid Biopsy Cancer Diagnostics Phase 5 Market Size, Share & Growth Report 2026-2035

The Global Liquid Biopsy Cancer Diagnostics Market size was valued at USD 92 Billion in 2025 and is projected to reach USD 291.6 Billion by 2035, expanding at a CAGR of 21.7%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026336 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,500
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1057CAGR: 25.4%

In Silico Drug Discovery Phase 5 Market Size, Share & Growth Report 2026-2035

The Global In Silico Drug Discovery Market size was valued at USD 96.8 Billion in 2025 and is projected to reach USD 342.7 Billion by 2035, expanding at a CAGR of 25.4%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026337 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,550
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1058CAGR: 29.1%

Cell Therapy Manufacturing Phase 5 Market Size, Share & Growth Report 2026-2035

The Global Cell Therapy Manufacturing Market size was valued at USD 101.6 Billion in 2025 and is projected to reach USD 397.3 Billion by 2035, expanding at a CAGR of 29.1%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026338 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,600
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1059CAGR: 32.8%

MRNA Vaccines & Therapeutics Phase 5 Market Size, Share & Growth Report 2026-2035

The Global MRNA Vaccines & Therapeutics Market size was valued at USD 106.4 Billion in 2025 and is projected to reach USD 455.4 Billion by 2035, expanding at a CAGR of 32.8%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026339 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,650
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1060CAGR: 36.5%

Radiopharmaceuticals & Nuclear Medicine Phase 6 Market Size, Share & Growth Report 2026-2035

The Global Radiopharmaceuticals & Nuclear Medicine Market size was valued at USD 111.2 Billion in 2025 and is projected to reach USD 517.1 Billion by 2035, expanding at a CAGR of 36.5%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026340 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,700
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1061CAGR: 8.2%

Artificial Intelligence in Healthcare Phase 6 Market Size, Share & Growth Report 2026-2035

The Global Artificial Intelligence in Healthcare Market size was valued at USD 116 Billion in 2025 and is projected to reach USD 211.1 Billion by 2035, expanding at a CAGR of 8.2%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026341 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,750
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1062CAGR: 11.9%

GLP-1 Weight Loss Therapeutics Phase 6 Market Size, Share & Growth Report 2026-2035

The Global GLP-1 Weight Loss Therapeutics Market size was valued at USD 120.8 Billion in 2025 and is projected to reach USD 264.6 Billion by 2035, expanding at a CAGR of 11.9%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026342 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,800
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1063CAGR: 15.6%

Gene Therapy & CRISPR Phase 6 Market Size, Share & Growth Report 2026-2035

The Global Gene Therapy & CRISPR Market size was valued at USD 125.6 Billion in 2025 and is projected to reach USD 321.5 Billion by 2035, expanding at a CAGR of 15.6%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026343 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,850
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1064CAGR: 19.3%

Clinical Trial Data Analytics Phase 6 Market Size, Share & Growth Report 2026-2035

The Global Clinical Trial Data Analytics Market size was valued at USD 130.4 Billion in 2025 and is projected to reach USD 382.1 Billion by 2035, expanding at a CAGR of 19.3%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026344 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,900
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1065CAGR: 23%

Digital Pathology Systems Phase 6 Market Size, Share & Growth Report 2026-2035

The Global Digital Pathology Systems Market size was valued at USD 135.2 Billion in 2025 and is projected to reach USD 446.2 Billion by 2035, expanding at a CAGR of 23%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026345 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,950
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1066CAGR: 26.7%

Surgical Robotics Equipment Phase 6 Market Size, Share & Growth Report 2026-2035

The Global Surgical Robotics Equipment Market size was valued at USD 140 Billion in 2025 and is projected to reach USD 513.8 Billion by 2035, expanding at a CAGR of 26.7%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026346 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,000
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1067CAGR: 30.4%

Next-Gen Sequencing NGS Phase 6 Market Size, Share & Growth Report 2026-2035

The Global Next-Gen Sequencing NGS Market size was valued at USD 144.8 Billion in 2025 and is projected to reach USD 585 Billion by 2035, expanding at a CAGR of 30.4%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026347 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,050
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1068CAGR: 34.1%

Liquid Biopsy Cancer Diagnostics Phase 6 Market Size, Share & Growth Report 2026-2035

The Global Liquid Biopsy Cancer Diagnostics Market size was valued at USD 149.6 Billion in 2025 and is projected to reach USD 659.7 Billion by 2035, expanding at a CAGR of 34.1%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026348 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,100
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1069CAGR: 37.8%

In Silico Drug Discovery Phase 6 Market Size, Share & Growth Report 2026-2035

The Global In Silico Drug Discovery Market size was valued at USD 154.4 Billion in 2025 and is projected to reach USD 738 Billion by 2035, expanding at a CAGR of 37.8%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026349 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,150
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1070CAGR: 9.5%

Cell Therapy Manufacturing Phase 6 Market Size, Share & Growth Report 2026-2035

The Global Cell Therapy Manufacturing Market size was valued at USD 159.2 Billion in 2025 and is projected to reach USD 310.4 Billion by 2035, expanding at a CAGR of 9.5%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026350 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,200
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1071CAGR: 13.2%

MRNA Vaccines & Therapeutics Phase 6 Market Size, Share & Growth Report 2026-2035

The Global MRNA Vaccines & Therapeutics Market size was valued at USD 164 Billion in 2025 and is projected to reach USD 380.5 Billion by 2035, expanding at a CAGR of 13.2%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026351 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,250
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1072CAGR: 16.9%

Radiopharmaceuticals & Nuclear Medicine Phase 7 Market Size, Share & Growth Report 2026-2035

The Global Radiopharmaceuticals & Nuclear Medicine Market size was valued at USD 168.8 Billion in 2025 and is projected to reach USD 454.1 Billion by 2035, expanding at a CAGR of 16.9%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026352 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,400
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1073CAGR: 20.6%

Artificial Intelligence in Healthcare Phase 7 Market Size, Share & Growth Report 2026-2035

The Global Artificial Intelligence in Healthcare Market size was valued at USD 173.6 Billion in 2025 and is projected to reach USD 531.2 Billion by 2035, expanding at a CAGR of 20.6%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026353 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,450
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1074CAGR: 24.3%

GLP-1 Weight Loss Therapeutics Phase 7 Market Size, Share & Growth Report 2026-2035

The Global GLP-1 Weight Loss Therapeutics Market size was valued at USD 178.4 Billion in 2025 and is projected to reach USD 611.9 Billion by 2035, expanding at a CAGR of 24.3%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026354 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,500
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1075CAGR: 28%

Gene Therapy & CRISPR Phase 7 Market Size, Share & Growth Report 2026-2035

The Global Gene Therapy & CRISPR Market size was valued at USD 3.2 Billion in 2025 and is projected to reach USD 12.2 Billion by 2035, expanding at a CAGR of 28%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026355 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,550
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1076CAGR: 31.7%

Clinical Trial Data Analytics Phase 7 Market Size, Share & Growth Report 2026-2035

The Global Clinical Trial Data Analytics Market size was valued at USD 8 Billion in 2025 and is projected to reach USD 33.4 Billion by 2035, expanding at a CAGR of 31.7%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026356 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,600
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1077CAGR: 35.4%

Digital Pathology Systems Phase 7 Market Size, Share & Growth Report 2026-2035

The Global Digital Pathology Systems Market size was valued at USD 12.8 Billion in 2025 and is projected to reach USD 58.1 Billion by 2035, expanding at a CAGR of 35.4%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026357 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,650
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1078CAGR: 7.1%

Surgical Robotics Equipment Phase 7 Market Size, Share & Growth Report 2026-2035

The Global Surgical Robotics Equipment Market size was valued at USD 17.6 Billion in 2025 and is projected to reach USD 30.1 Billion by 2035, expanding at a CAGR of 7.1%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026358 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,700
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1079CAGR: 10.8%

Next-Gen Sequencing NGS Phase 7 Market Size, Share & Growth Report 2026-2035

The Global Next-Gen Sequencing NGS Market size was valued at USD 22.4 Billion in 2025 and is projected to reach USD 46.6 Billion by 2035, expanding at a CAGR of 10.8%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026359 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,750
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1080CAGR: 14.5%

Liquid Biopsy Cancer Diagnostics Phase 7 Market Size, Share & Growth Report 2026-2035

The Global Liquid Biopsy Cancer Diagnostics Market size was valued at USD 27.2 Billion in 2025 and is projected to reach USD 66.6 Billion by 2035, expanding at a CAGR of 14.5%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026360 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,800
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1081CAGR: 18.2%

In Silico Drug Discovery Phase 7 Market Size, Share & Growth Report 2026-2035

The Global In Silico Drug Discovery Market size was valued at USD 32 Billion in 2025 and is projected to reach USD 90.2 Billion by 2035, expanding at a CAGR of 18.2%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026361 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,850
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1082CAGR: 21.9%

Cell Therapy Manufacturing Phase 7 Market Size, Share & Growth Report 2026-2035

The Global Cell Therapy Manufacturing Market size was valued at USD 36.8 Billion in 2025 and is projected to reach USD 117.4 Billion by 2035, expanding at a CAGR of 21.9%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026362 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,900
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1083CAGR: 25.6%

MRNA Vaccines & Therapeutics Phase 7 Market Size, Share & Growth Report 2026-2035

The Global MRNA Vaccines & Therapeutics Market size was valued at USD 41.6 Billion in 2025 and is projected to reach USD 148.1 Billion by 2035, expanding at a CAGR of 25.6%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026363 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,950
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1084CAGR: 29.3%

Radiopharmaceuticals & Nuclear Medicine Phase 8 Market Size, Share & Growth Report 2026-2035

The Global Radiopharmaceuticals & Nuclear Medicine Market size was valued at USD 46.4 Billion in 2025 and is projected to reach USD 182.4 Billion by 2035, expanding at a CAGR of 29.3%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026364 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,000
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1085CAGR: 33%

Artificial Intelligence in Healthcare Phase 8 Market Size, Share & Growth Report 2026-2035

The Global Artificial Intelligence in Healthcare Market size was valued at USD 51.2 Billion in 2025 and is projected to reach USD 220.2 Billion by 2035, expanding at a CAGR of 33%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026365 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,050
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1086CAGR: 36.7%

GLP-1 Weight Loss Therapeutics Phase 8 Market Size, Share & Growth Report 2026-2035

The Global GLP-1 Weight Loss Therapeutics Market size was valued at USD 56 Billion in 2025 and is projected to reach USD 261.5 Billion by 2035, expanding at a CAGR of 36.7%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026366 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,100
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1087CAGR: 8.4%

Gene Therapy & CRISPR Phase 8 Market Size, Share & Growth Report 2026-2035

The Global Gene Therapy & CRISPR Market size was valued at USD 60.8 Billion in 2025 and is projected to reach USD 111.9 Billion by 2035, expanding at a CAGR of 8.4%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026367 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,150
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1088CAGR: 12.1%

Clinical Trial Data Analytics Phase 8 Market Size, Share & Growth Report 2026-2035

The Global Clinical Trial Data Analytics Market size was valued at USD 65.6 Billion in 2025 and is projected to reach USD 145 Billion by 2035, expanding at a CAGR of 12.1%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026368 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,200
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1089CAGR: 15.8%

Digital Pathology Systems Phase 8 Market Size, Share & Growth Report 2026-2035

The Global Digital Pathology Systems Market size was valued at USD 70.4 Billion in 2025 and is projected to reach USD 181.6 Billion by 2035, expanding at a CAGR of 15.8%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026369 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$4,250
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1090CAGR: 19.5%

Surgical Robotics Equipment Phase 8 Market Size, Share & Growth Report 2026-2035

The Global Surgical Robotics Equipment Market size was valued at USD 75.2 Billion in 2025 and is projected to reach USD 221.8 Billion by 2035, expanding at a CAGR of 19.5%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026370 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,400
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1091CAGR: 23.2%

Next-Gen Sequencing NGS Phase 8 Market Size, Share & Growth Report 2026-2035

The Global Next-Gen Sequencing NGS Market size was valued at USD 80 Billion in 2025 and is projected to reach USD 265.6 Billion by 2035, expanding at a CAGR of 23.2%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026371 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,450
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1092CAGR: 26.9%

Liquid Biopsy Cancer Diagnostics Phase 8 Market Size, Share & Growth Report 2026-2035

The Global Liquid Biopsy Cancer Diagnostics Market size was valued at USD 84.8 Billion in 2025 and is projected to reach USD 312.9 Billion by 2035, expanding at a CAGR of 26.9%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026372 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,500
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1093CAGR: 30.6%

In Silico Drug Discovery Phase 8 Market Size, Share & Growth Report 2026-2035

The Global In Silico Drug Discovery Market size was valued at USD 89.6 Billion in 2025 and is projected to reach USD 363.8 Billion by 2035, expanding at a CAGR of 30.6%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026373 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,550
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1094CAGR: 34.3%

Cell Therapy Manufacturing Phase 8 Market Size, Share & Growth Report 2026-2035

The Global Cell Therapy Manufacturing Market size was valued at USD 94.4 Billion in 2025 and is projected to reach USD 418.2 Billion by 2035, expanding at a CAGR of 34.3%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026374 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,600
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1095CAGR: 38%

MRNA Vaccines & Therapeutics Phase 8 Market Size, Share & Growth Report 2026-2035

The Global MRNA Vaccines & Therapeutics Market size was valued at USD 99.2 Billion in 2025 and is projected to reach USD 476.2 Billion by 2035, expanding at a CAGR of 38%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026375 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,650
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1096CAGR: 9.7%

Radiopharmaceuticals & Nuclear Medicine Phase 9 Market Size, Share & Growth Report 2026-2035

The Global Radiopharmaceuticals & Nuclear Medicine Market size was valued at USD 104 Billion in 2025 and is projected to reach USD 204.9 Billion by 2035, expanding at a CAGR of 9.7%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026376 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,700
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1097CAGR: 13.4%

Artificial Intelligence in Healthcare Phase 9 Market Size, Share & Growth Report 2026-2035

The Global Artificial Intelligence in Healthcare Market size was valued at USD 108.8 Billion in 2025 and is projected to reach USD 254.6 Billion by 2035, expanding at a CAGR of 13.4%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026377 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,750
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1098CAGR: 17.1%

GLP-1 Weight Loss Therapeutics Phase 9 Market Size, Share & Growth Report 2026-2035

The Global GLP-1 Weight Loss Therapeutics Market size was valued at USD 113.6 Billion in 2025 and is projected to reach USD 307.9 Billion by 2035, expanding at a CAGR of 17.1%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026378 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,800
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1099CAGR: 20.8%

Gene Therapy & CRISPR Phase 9 Market Size, Share & Growth Report 2026-2035

The Global Gene Therapy & CRISPR Market size was valued at USD 118.4 Billion in 2025 and is projected to reach USD 364.7 Billion by 2035, expanding at a CAGR of 20.8%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026379 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,850
Instant PDF + Excel
View Full Report
Healthcare & BiotechnologyCode: AMR-HEA-1100CAGR: 24.5%

Clinical Trial Data Analytics Phase 9 Market Size, Share & Growth Report 2026-2035

The Global Clinical Trial Data Analytics Market size was valued at USD 123.2 Billion in 2025 and is projected to reach USD 425 Billion by 2035, expanding at a CAGR of 24.5%. Major factors driving growth include rapid technology integration, regulatory support, and expanding commercial adoption across key geographies.

August 2026380 PagesForecast: 2026-2035 (3-Yr, 5-Yr, 10-Yr)
Single User License
$3,900
Instant PDF + Excel
View Full Report